Literature DB >> 6816583

Serum-induced lysis of Pseudomonas aeruginosa.

T Meshulam, H Verbrugh, J Verhoef.   

Abstract

The sensitivity of 12 Pseudomonas aeruginosa strains (5 mucoid and 7 non-mucoid strains) to serum and the interaction of these strains with the complement system was studied. Five strains (4 mucoid and 1 non-mucoid strains) were lysed in 20% normal serum as measured by the release of radiolabelled material from 3H-adenine labelled bacteria. Three of these strains were also lysed in MgEGTA chelated serum. All strains activated complement via the classical pathway, and six strains were able to activate the alternative complement pathway as well. Slime production did not interfere with bacteriolysis and complement consumption.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6816583     DOI: 10.1007/bf02014132

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  21 in total

1.  DNA release as a direct measure of microbial killing. I. Serum bactericidal activity.

Authors:  A M Friedlander
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

2.  [Research on O-antigens of Pseudomonas aeruginosa].

Authors:  I HABS
Journal:  Z Hyg Infektionskr       Date:  1957

3.  Gram-negative bacillary pneumonia in the compromised host.

Authors:  M Valdivieso; B Gil-extremera; J Zornoza; V Rodriquez; G P Bodey
Journal:  Medicine (Baltimore)       Date:  1977-05       Impact factor: 1.889

4.  Pseudomonas bacteremia in patients with malignant diseases.

Authors:  J P Whitecar; M Luna; G P Bodey
Journal:  Am J Med Sci       Date:  1970-10       Impact factor: 2.378

5.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

Authors:  G P Bodey; M Buckley; Y S Sathe; E J Freireich
Journal:  Ann Intern Med       Date:  1966-02       Impact factor: 25.391

6.  Bacteremia due to Pseudomonas aeruginosa complicating neoplastic disease: a progress report.

Authors:  M L Tapper; D Armstrong
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

7.  Pseudomonas aeruginosa vasculitis and bacteremia following conjunctivitis: a simple model of fatal pseudomonas infection in neutropenia.

Authors:  E J Ziegler; H Douglas
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

8.  Lipopolysaccharide pseudomonas vaccine: efficacy against pulmonary infection with Pseudomonas aeruginosa.

Authors:  J E Pennington
Journal:  J Infect Dis       Date:  1979-07       Impact factor: 5.226

9.  Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations.

Authors:  L S Young; W J Martin; R D Meyer; R J Weinstein; E T Anderson
Journal:  Ann Intern Med       Date:  1977-04       Impact factor: 25.391

10.  Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.

Authors:  N Holby; S Olling
Journal:  Acta Pathol Microbiol Scand C       Date:  1977-04
View more
  6 in total

1.  Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.

Authors:  N L Schiller; K A Joiner
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

2.  Determination of serum bactericidal activity against Escherichia coli by an automated photometric method.

Authors:  F Crokaert; M J Lismont; M P van der Linden; E Yourassowsky
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

3.  Serum sensitivity of a Pseudomonas aeruginosa mucoid strain.

Authors:  N L Schiller; M J Alazard; R S Borowski
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

4.  Differential complement activation and susceptibility to human serum bactericidal action by Vibrio species.

Authors:  M L Tamplin; S Specter; G E Rodrick; H Friedman
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

5.  Characterization of the susceptibility of Pseudomonas aeruginosa to complement-mediated killing: role of antibodies to the rough lipopolysaccharide on serum-sensitive strains.

Authors:  N L Schiller
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

6.  Age-related variations in the in vitro bactericidal activity of human sera against Pseudomonas aeruginosa.

Authors:  Akram Khan; Isfahan Tauseef; Bibi Aalia; Muhammad Azam Khan; Sadia Akbar; Nighat Sultana; Kashif S Haleem
Journal:  Cent Eur J Immunol       Date:  2018-03-30       Impact factor: 2.085

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.